Skip to main content

Jupiter Wellness, Inc. (JUPW)

NASDAQ: JUPW · IEX Real-Time Price · USD
1.86
-0.06 (-3.13%)
After-hours:Oct 21, 2021 7:35 PM EDT
1.92
0.01 (0.52%)
At close: Oct 21, 4:00 PM
Market Cap43.79M
Revenue (ttm)1.13M
Net Income (ttm)-11.72M
Shares Out11.36M
EPS (ttm)-1.24
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume662,491
Open1.95
Previous Close1.91
Day's Range1.82 - 1.95
52-Week Range1.25 - 8.88
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About JUPW

Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the ...

IndustryDrug Manufacturers-Specialty & Generic
IPO DateOct 30, 2020
Employees5
Stock ExchangeNASDAQ
Ticker SymbolJUPW
Full Company Profile

Financial Performance

In 2020, JUPW's revenue was $1.07 million, an increase of 16,409.14% compared to the previous year's $6,455. Losses were -$6.29 million, 579.6% more than in 2019.

Financial Statements

News

Jupiter Wellness Announces First Patient Dosing for Double-Blinded Placebo Controlled Trial of JW-300 for the Treatme...

JUPITER, FL / ACCESSWIRE / October 19, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a clinical stage company developing a cannabinoid receptor agonist for the treatment of first degree burns, announced ...

2 days ago - Accesswire

Jupiter Wellness Provides Shareholder Update on Multiple Clinical & Commercial Milestones

JUPITER, FL / ACCESSWIRE / October 7, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today provided an update on its advancing clinical programs and commercial progress. Commercial: Photocil™ to Launch in...

2 weeks ago - Accesswire

Jupiter Wellness Announces Multi-Year Extension of Endorsement Agreement with Pro Golfer Ernie Els

Pro Golf Hall of Fame Legend Extends Endorsement of CaniSun Suncare Products JUPITER, FL / ACCESSWIRE / September 8, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a developer of enhanced skin care therap...

1 month ago - Accesswire

Jupiter Wellness Submitted a Pre-IND Meeting Request with the US FDA for its Proposed Clinical Program of JW-100 as a...

Following receipt of a Pre-Assignment number from the FDA Jupiter Wellness requests Pre-IND meeting JUPITER, FL / ACCESSWIRE / August 23, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a developer of enha...

1 month ago - Accesswire

Jupiter Wellness Applies for IND number from the US Food and Drug Administration

Following positive results from the JW-100 investigator initiated trials for Eczema, Jupiter Wellness to commence US FDA program JUPITER, FL / ACCESSWIRE / August 16, 2021 / Jupiter Wellness, Inc. (NASD...

2 months ago - Accesswire

Aegis Capital Corp. acted as Sole Bookrunner on a $32.5 Million Follow-On Offering of Common Stock and Warrants for J...

NEW YORK, NY / ACCESSWIRE / July 26, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $32.5 Million Follow-On Offering of Common Stock and Warrants for Jupiter Wellness, Inc. (NASDAQ:JUPW). Abou...

2 months ago - Accesswire

Jupiter Wellness Closes $32.5 Million Underwritten Public Offering of Common Stock and Warrants

JUPITER, FL / ACCESSWIRE / July 26, 2021 / Jupiter Wellness, Inc. (the "Company") (NASDAQ:JUPW), today announced the closing of an underwritten public offering (the "Offering") of 11,066,258 shares (the...

2 months ago - Accesswire

Jupiter Wellness Prices $32.5 Million Underwritten Public Offering of Common Stock and Warrants

JUPITER, FL / ACCESSWIRE / July 21, 2021 / Jupiter Wellness, Inc. (the "Company") (NASDAQ:JUPW), today announced the pricing of an underwritten public offering (the "Offering") of 11,066,258 shares (the...

2 months ago - Accesswire

Jupiter Wellness Announces Multi-Year Distribution Agreement with Rigour International for Expansion in Asia

JUPITER, FL / ACCESSWIRE / July 19, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a multi-year agreement with Rigour International LLC as the exclusive authorized distributor of Jupiter W...

3 months ago - Accesswire

Jupiter Wellness Announces Appointment of Dr. Andy Goren to Scientific Advisory Board

JUPITER, FL / ACCESSWIRE / July 15, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced that Dr Andy Goren has been appointed to its Scientific Advisory Board. Dr. Andy Goren has more than twen...

3 months ago - Accesswire

Jupiter Wellness Announces initiation of Head-to-Head Trial Comparing JW-100 and Eucrisa(R) for the Treatment of Mild...

JUPITER, FL / ACCESSWIRE / July 13, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a head-to-head trial comparing JW-100 lotion with Eucrisa crisaborole ointment 2% for the treatment of pa...

3 months ago - Accesswire

Jupiter Wellness Licenses Photocil(TM), a Novel Topical Treatment of Psoriasis, Vitiligo, Pruritis and Atopic Dermatitis

*Photo-Therapy in a tub JUPITER, FL / ACCESSWIRE / July 9, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced they have entered into an exclusive agreement to license Photocil™, a novel patent...

3 months ago - Accesswire

Results of Clinical Study Showing That JW 100 Significantly Reduces ISGA Score in Atopic Dermatitis (AD) Published

https://pubmed.ncbi.nlm.nih.gov/34056830/ JUPITER, FL / ACCESSWIRE / June 22, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced the publication of clinical study results to investigate the sa...

3 months ago - Accesswire

Jupiter Wellness Licenses Patents for the Treatment of Contact Dermatitis

JUPITER, FL / ACCESSWIRE / June 17, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a licensing agreement for two patents covering the use of Aspartame for the treatment of Contact Dermatit...

4 months ago - Accesswire

Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments

Four Indications in Clinical Development JUPITER, FL / ACCESSWIRE / April 29, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellnes...

5 months ago - Accesswire

Jupiter Wellness Enters into Letter of Intent to Acquire JustCBD and its Affiliates

Accretive acquisition would add a profitable company with approximately $28 million of revenue in 2020 (unaudited) JUPITER, FL / ACCESSWIRE / April 20, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a lea...

6 months ago - Accesswire

Jupiter Wellness to Support Growth in CBD-Based Pharma & Consumer Products

JUPITER, FL / ACCESSWIRE / April 16, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced it has appoin...

6 months ago - Accesswire

Jupiter Wellness' SRM Division Sees Significant Monthly Sales Growth as Global Theme Parks Set to Reopen

JUPITER, FL / ACCESSWIRE / March 11, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a CBD-based pharmaceuticals company with 4 significant treatments in skin health for eczema, skin cancer, burns and herp...

7 months ago - Accesswire

Jupiter Wellness Launches New Consumer Products Website: www.cbdcaring.com

Ecommerce site is expanded and optimized for Company's growing portfolio of CBD wellness products JUPITER, FL / ACCESSWIRE / March 2, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a CBD-based pharmaceuti...

7 months ago - Accesswire

Jupiter Wellness Completes Patient Enrollment in Clinical Study of Novel Cannabidiol Lotion JW-100 for the Treatment ...

Data Expected Q1 2021 From Study of 66 Patients JUPITER, FL / ACCESSWIRE / December 22, 2020 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics a...

9 months ago - Accesswire